Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience.
Paul BastardNathalie CozicRégis BrionNathalie GasparSophie Piperno-NeumannCamille CorderoEstelle Leculée-ThébaudAnne Gomez-MascardFrançoise RédiniAntonin MarchaisRaina IkonomovaMorgane CleirecValérie LaurenceCharlotte RigaudRachid AbbasFranck VerrecchiaLaurence BrugieresVeronique Minard ColinPublished in: Pediatric blood & cancer (2024)
We identified NLR-W4 as a potential early biomarker for survival in patients with OST treated with M-EI chemotherapy. Further studies are required to confirm the prognostic value of NLR and better identify immune mechanisms involved in disease surveillance.